Product Recalls in North Dakota

Product recalls affecting North Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to North Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,526 recalls have been distributed to North Dakota in the last 12 months.

47,938 total recalls
2,526 in last 12 months

Showing 1162111640 of 13,369 recalls

DrugJanuary 24, 2014· MyNicNaxs, Inc.

Recalled Item: REDUCE WEIGHT FRUTA PLANTA Capsules Recalled by MyNicNaxs, Inc. Due to...

The Issue: Marketed Without an Approved NDA/ANDA: Product was found to contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 24, 2014· Teva Pharmaceuticals USA

Recalled Item: Teva Hydroxyzine Pamoate Capsules Recalled by Teva Pharmaceuticals USA Due...

The Issue: CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2014· MyNicNaxs, Inc.

Recalled Item: Magic Slim capsules Recalled by MyNicNaxs, Inc. Due to Undeclared Active

The Issue: Marketed Without an Approved NDA/ANDA: Product was found to contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 24, 2014· MyNicNaxs, Inc.

Recalled Item: Slim Xtreme Weight loss capsules Recalled by MyNicNaxs, Inc. Due to...

The Issue: Marketed Without an Approved NDA/ANDA: Product was found to contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 24, 2014· Teva Pharmaceuticals USA

Recalled Item: Teva Hydroxyzine Pamoate Capsules Recalled by Teva Pharmaceuticals USA Due...

The Issue: CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 22, 2014· Fresenius Kabi USA, LLC

Recalled Item: Heparin Sodium Injection Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Subpotent; 18 month time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· Ranbaxy Inc.

Recalled Item: Atorvastatin Calcium Tablets Recalled by Ranbaxy Inc. Due to Presence of...

The Issue: Presence of Foreign Tablets: A product complaint was received by a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Cooling Eye Drops Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Dry Eye Recalled by The Mentholatum Co. Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Redness Relief Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Redness Relief Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Redness Relief Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2014· Traxx International Corp

Recalled Item: Guaifenesin USP Recalled by Traxx International Corp Due to Presence of...

The Issue: Presence of Foreign Matter: Guaifenesin API powder is being recalled due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2014· Mylan Pharmaceuticals Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Pharmaceuticals Inc. Due to...

The Issue: Subpotent Drug: Assay results obtained during stability testing for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: This recall of LIPTRUZET is being initiated due to packaging defects. Some...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: This recall of LIPTRUZET is being initiated due to packaging defects. Some...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: Defective Container; some of the outer laminate foil pouches allowed in air...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: This recall of LIPTRUZET is being initiated due to packaging defects. Some...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2014· HUMAN SCIENCE FOUNDATION

Recalled Item: PRO ArthMax Dietary Supplement tablets Recalled by HUMAN SCIENCE FOUNDATION...

The Issue: Marketed without an Approved NDA/ANDA; FDA analysis found the product to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 10, 2014· Dermamedics, L.L.C.

Recalled Item: Therametics Complexion Repair Topical Rehydrating Emulsion in 50 ml and...

The Issue: Marketed without an Approved NDA/ANDA: FDA has determined that the products...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund